AbbVie Declares Quarterly Dividend
AbbVie (NYSE: ABBV) has announced a quarterly cash dividend of $1.64 per share, payable on May 15, 2025, to stockholders of record as of April 15, 2025.
Sentiment and the balance of points
Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.
Rhea-AI Summary
AbbVie (NYSE: ABBV) has announced a quarterly cash dividend of $1.64 per share, payable on May 15, 2025, to stockholders of record as of April 15, 2025. The company has demonstrated strong dividend growth, increasing its dividend by 310 percent since its establishment in 2013. AbbVie maintains its position in the prestigious S&P Dividend Aristocrats Index, which recognizes companies with at least 25 consecutive years of dividend increases.
Positive
- Quarterly dividend payment of $1.64 per share maintained
- 310% dividend growth since 2013
- Continued membership in S&P Dividend Aristocrats Index, indicating strong dividend reliability
Negative
- None.
Details
News Market Reaction – ABBV
The recorded move for ABBV in the trading session of this news was +0.23%.
Data tracked by StockTitan Argus. Session date unavailable.
AI-generated analysis. How Rhea-AI works. Not financial advice.
The cash dividend is payable May 15, 2025, to stockholders of record at the close of business on April 15, 2025.
Since the company's inception in 2013, AbbVie has increased its dividend by 310 percent. AbbVie is a member of the S&P Dividend Aristocrats Index, which tracks companies that have annually increased their dividend for at least 25 consecutive years.
About AbbVie
AbbVie's mission is to discover and deliver innovative medicines and solutions that solve serious health issues today and address the medical challenges of tomorrow. We strive to have a remarkable impact on people's lives across several key therapeutic areas – immunology, oncology, neuroscience, and eye care – and products and services in our Allergan Aesthetics portfolio. For more information about AbbVie, please visit us at www.abbvie.com. Follow @abbvie on LinkedIn, Facebook, Instagram, X (formerly Twitter), and YouTube.
Media: Gabby Tarbert (224) 244-0111 | Investors: Liz Shea |
View original content to download multimedia:https://www.prnewswire.com/news-releases/abbvie-declares-quarterly-dividend-302376276.html
SOURCE AbbVie
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.